Viewing Study NCT00526968


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-02-25 @ 2:41 AM
Study NCT ID: NCT00526968
Status: COMPLETED
Last Update Posted: 2008-02-18
First Post: 2007-09-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function
Sponsor: Evotec Neurosciences GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module